Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Tagrisso

Osimertinib Mesylate

Open in the dashboard

Part D claims

79,546

Prescriptions dispensed, refills included

Drug cost

$1,338,277,911

Paid at the pharmacy, in all

Prescribers

2,794

With 11 or more claims of it

In 2024, Medicare Part D recorded 79,546 claims for Tagrisso (osimertinib mesylate) from 2,794 prescribers, at a total drug cost of $1.3 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Tagrisso by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 535 19,076 $321,288,991
NY 216 9,925 $170,161,090
FL 183 5,399 $91,171,735
TX 168 4,197 $71,549,713
PA 135 3,149 $53,071,497
MA 96 2,994 $49,675,613
IL 96 2,256 $37,679,922
NJ 70 1,940 $32,086,639
MI 73 1,888 $30,876,296
MD 69 1,817 $30,880,529
NC 69 1,789 $29,429,074
GA 77 1,767 $29,404,474
OH 82 1,752 $29,945,478
WA 60 1,687 $28,656,355
VA 69 1,542 $25,810,679
The other 38 states and territories
State Prescribers Claims Drug cost
CT 35 1,238 $20,515,958
AZ 49 1,150 $19,090,029
CO 48 1,117 $18,297,435
SC 47 1,104 $18,487,407
MN 53 1,082 $18,039,035
IN 51 1,053 $17,416,356
OR 34 1,017 $17,251,310
TN 46 953 $15,585,158
MO 44 850 $14,609,304
HI 24 786 $13,557,306
WI 38 731 $12,430,294
AL 29 650 $10,597,633
LA 31 629 $10,491,526
KY 23 607 $9,871,697
PR 25 528 $9,022,897
KS 14 423 $7,102,300
OK 17 379 $6,124,396
NV 20 376 $6,529,033
NE 13 359 $5,837,629
UT 17 340 $5,914,676
AR 16 339 $5,714,998
IA 12 281 $4,435,380
RI 10 273 $4,528,694
ID 15 255 $4,217,179
WV 8 235 $3,832,790
NH 9 211 $3,468,922
DC 6 198 $3,266,565
SD 10 186 $2,976,398
MS 10 181 $3,021,613
NM 7 161 $2,723,891
VT 6 155 $2,482,585
ME 8 134 $2,147,527
DE 3 123 $2,197,875
ND 6 81 $1,332,367
AK 4 73 $1,417,641
MT 6 71 $1,186,578
WY 1 28 $461,056
GU 1 11 $406,392

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 15
Part D claims for Tagrisso by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 1,556 39,356 $661,416,627
Medical Oncology 532 17,943 $301,895,620
Nurse Practitioner 304 9,611 $160,323,446
Internal Medicine 209 6,482 $110,729,312
Physician Assistant 107 3,340 $56,423,141
Hematology 49 1,327 $22,559,399
Pharmacist 14 839 $14,163,053
Hematopoietic Cell Transplantation and Cellular Therapy 4 187 $3,131,365
Student in an Organized Health Care Education/Training Program 7 154 $2,563,624
Hospitalist 4 129 $2,155,461
Certified Clinical Nurse Specialist 3 75 $1,219,977
Hospice and Palliative Care 2 66 $1,084,310
Geriatric Medicine 1 14 $232,338
Specialist 1 12 $210,971
Registered Nurse 1 11 $169,266

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Cathleen Power Nurse Practitioner MA 359 $6,098,493 None on record
Jason Kao Physician Assistant CA 348 $6,069,195 None on record
Jennifer Tseng Hematology-Oncology FL 312 $5,100,120 None on record
Jamie Chaft Medical Oncology NY 298 $4,868,310 $6,300
Judy Pagtama Nurse Practitioner CA 289 $4,699,748 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record